Vor Biopharma (VOR) Stock Statistics & Valuation Metrics

Vor Biopharma has a market cap or net worth of $714.15M. The enterprise value is -$298.83M.

Vor Biopharma has 48,847,504 shares outstanding. The number of shares has decreased by -2.65% in one year.

Vor Biopharma’s return on equity (ROE) is 4.24 and return on invested capital (ROIC) is -84.61%.

The current PE Ratio of Vor Biopharma is ―. Vor Biopharma’s PEG ratio is -0.00173.

In the last 12 months, Vor Biopharma had revenue of 0.00 and earned -695.98M in profits. Earnings per share was -70.50.

In the last 12 months, operating cash flow was -142.71M and capital expenditures -941.00K, giving a free cash flow of -143.65M billion.

Vor Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―

Vor Biopharma upcoming earnings date is May 7, 2026, Before Open (Confirmed).

Vor Biopharma as a current ratio of 18.20, with Debt / Equity ratio of -1.83%

In the past 12 months, Vor Biopharma has paid 0.00 in taxes.

Vor Biopharma EV to EBITDA ratio is 0.72, with an EV/FCF ratio of 1.84.

Vor Biopharma has $455.21M in cash and marketable securities with $3.00M in debt, giving a net cash position of $452.21M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Vor Biopharma is $36.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy